EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice

Annals of the Rheumatic Diseases

Volumn 74, Issue 7, 2015, Pages 1327-1339

  Mandl, P ^a   Navarro Compan V ^b,c   Terslev, L ^d   Aegerter, P ^e   Van Der Heijde, D ^b   D'Agostino, M A ^e   Baraliakos, X ^f   Pedersen, S J ^g   Jurik, A G ^h   Naredo, E ⁱ   Schueller Weidekamm, C ^a   Weber, U ^j   Wick, M C ^k   Bakker, P A C ^b   Filippucci, E ^l   Conaghan, P G ^m   Rudwaleit, M ⁿ   Schett, G ^o   Sieper, J ⁿ   Tarp, S ^d   Marzo Ortega, H ^m   Ostergaard M ^d   more..

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d Mental Health Services CPH   (Denmark)

^e HÔPITAL AMBROISE PARÉ   (France)

^f RHEUMAZENTRUM RUHRGEBIET   (Germany)

^g GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^h AARHUS UNIVERSITY HOSPITAL   (Denmark)

ⁱ HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^j King Christian the Xth Hospital   (Denmark)

^k KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^l UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^m UNIVERSITY OF LEEDS   (United Kingdom)

ⁿ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^o UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BONE DENSITY; BONE RADIOGRAPHY; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; DISEASE COURSE; DUAL ENERGY X RAY ABSORPTIOMETRY; EUROPEAN LEAGUE AGAINST RHEUMATISM; EVIDENCE BASED MEDICINE; HUMAN; IMAGE ANALYSIS; MEDICAL SOCIETY; NUCLEAR MAGNETIC RESONANCE; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPONDYLARTHRITIS; SYSTEMATIC REVIEW; VISUAL ANALOG SCALE; CLASSIFICATION; CONSENSUS DEVELOPMENT; ECHOGRAPHY; EUROPE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PROCEDURES; RADIOGRAPHY; TREATMENT OUTCOME;

DIAGNOSTIC IMAGING; EUROPE; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOGRAPHY; SPONDYLARTHRITIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY;

EID: 84934909925     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-206971     Document Type: Review

References (176)

1. van Tubergen A, Weber U. Diagnosis and classification in spondyloarthritis: identifying a chameleon. Nat Rev Rheumatol 2012;8:253-61.
2. Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
3. Amor B, Dougados M, Mijiyawa M. Criteria of the classification of spondylarthropathies [French]. Rev Rhum 1990;57:85-9.
4. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
5. Khan MA, van der Linden SM. A wider spectrum of spondyloarthropathies. Semin Arthritis Rheum 1990;20:107-13.
6. Khan MA, van der Linden SM, Kushner I, et al. Spondylitic disease without radiological evidence of sacroiliitis in relatives of HLA-B27 positive patients. Arthritis Rheum 1985;28:40-3.
7. Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68:777-83.
8. Rudwaleit M, van der Heijde D, Landewé R, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011;70:25-31.
9. Braun J, Bollow M, Eggens U, et al. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum 1994;37:1039-45.
10. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155:529-36.
11. McNally E, Keogh C, Galvin R, et al. Diagnostic accuracy of a clinical prediction rule (CPR) for identifying patients with recent-onset undifferentiated arthritis who are at a high risk of developing rheumatoid arthritis: A systematic review and meta-analysis. Semin Arthritis Rheum 2014;43:498-507.
12. Dougados M, Betteridge N, Burmester GR, et al. EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees. Ann Rheum Dis 2004;63:1172-6.
13. Shekelle PG, Woolf SH, Eccles M, et al. Clinical guidelines: developing guidelines. BMJ 1999;318:593-6.
14. Blum U, Buitrago-Tellez C, Mundinger A, et al. Magnetic resonance imaging (MRI) for detection of active sacroiliitis - a prospective study comparing conventional radiography, scintigraphy, and contrast enhanced MRI. J Rheumatol 1996;23:2107-15.
15. Devauchelle-Pensec V, D'Agostino MA, Marion J, et al. Computed tomography scanning facilitates the diagnosis of sacroiliitis in patients with suspected spondylarthritis: results of a prospective multicenter French cohort study. Arthritis Rheum 2012;64:1412-19.
16. Goie The HS, Steven MM, van der Linden SM, et al. Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Br J Rheumatol 1985;24:242-9.
17. van Tubergen A, Heuft-Dorenbosch L, Schulpen G, et al. Radiographic assessment of sacroiliitis by radiologists and rheumatologists: does training improve quality? Ann Rheum Dis 2003;62:519-25.
18. Geijer M, Göthlin GG, Göthlin JH. The clinical utility of computed tomography compared to conventional radiography in diagnosing sacroiliitis. A retrospective study on 910 patients and literature review. J Rheumatol 2007;34:1561-5.
19. Bennett AN, McGonagle D, O'Connor P, et al. Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 2008;58:3413-18.
20. Marzo-Ortega H, McGonagle D, O'Connor P, et al. Baseline and 1-year magnetic resonance imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain. Relationship between symptoms, HLA-B27 and disease extent and persistence. Ann Rheum Dis 2009;68:1721-7.
21. Oostveen J, Prevo R, den Boer J, et al. Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography. A prospective, longitudinal study. J Rheumatol 1999;26:1953-8.
22. Weber U, Lambert RG, Pedersen SJ, et al. Assessment of structural lesions in sacroiliac joints enhances diagnostic utility of magnetic resonance imaging in early spondylarthritis. Arthritis Care Res (Hoboken) 2010;62:1763-71.
23. Weber U, Lambert RG, Østergaard M, et al. The diagnostic utility of magnetic resonance imaging in spondylarthritis: an international multicenter evaluation of one hundred eighty-seven subjects. Arthritis Rheum 2010;62:3048-58.
24. Weber U, Pedersen SJ, Zubler V, et al. What constitutes the characteristic fat lesion on MRI of the sacroiliac joints in early spondyloarthritis? Arthritis Rheum 2012;64(Suppl 10):1024.
25. Weber U, Zubler V, Pedersen SJ, et al. Development and validation of a magnetic resonance imaging reference criterion for defining a positive sacroiliac joint magnetic resonance imaging finding in spondyloarthritis. Arthritis Care Res Hoboken 2013;65:977-85.
26. Wick MC, Weiss RJ, Jaschke W, et al. Erosions are the most relevant magnetic resonance imaging features in quantification of sacroiliac joints in ankylosing spondylitis. J Rheumatol 2010;37:622-7.
27. Heuft-Dorenbosch L, Landewé R, Weijers R, et al. Combining information obtained from magnetic resonance imaging and conventional radiographs to detect sacroiliitis in patients with recent onset inflammatory back pain. Ann Rheum Dis 2006;65:804-8.
28. Bennett AN, Rehman A, Hensor EM, et al. Evaluation of the diagnostic utility of spinal magnetic resonance imaging in axial spondylarthritis. Arthritis Rheum 2009;60:1331-41.
29. Bennett AN, Rehman A, Hensor EM, et al. The fatty Romanus lesion: a non-inflammatory spinal MRI lesion specific for axial spondyloarthropathy. Ann Rheum Dis 2010;69:891-4.
30. Weber U, Hodler J, Kubik RA, et al. Sensitivity and specificity of spinal inflammatory lesions assessed by whole-body magnetic resonance imaging in patients with ankylosing spondylitis or recent-onset inflammatory back pain. Arthritis Rheum 2009;61:900-8.
31. Kim NR, Choi JY, Hong SH, et al. "MR corner sign": value for predicting presence of ankylosing spondylitis. AJR Am J Roentgenol 2008;191:124-8.
32. Weber U, Zubler V, Zhao Z, et al. Does spinal MRI add incremental diagnostic value to MRI of the sacroiliac joints alone in patients with non-radiographic axial spondyloarthritis? Ann Rheum Dis 2015;74:985-92.
33. Inanc N, Atagündüz P, Sen F, et al. The investigation of sacroiliitis with different imaging techniques in spondyloarthropathies. Rheumatol Int 2005;25:591-4.
34. Chase WF, Houk RW, Winn RE, et al. The clinical usefulness of radionuclide scintigraphy in suspected sacro-iliitis: a prospective study. Br J Rheumatol 1983;22:67-72.
35. Song IH, Brandt H, Rudwaleit M, et al. Limited diagnostic value of unilateral sacroiliitis in scintigraphy in assessing axial spondyloarthritis. J Rheumatol 2010;37:1200-2.
36. Klauser A, Halpern EJ, Frauscher F, et al. Inflammatory low back pain: high negative predictive value of contrast-enhanced color Doppler ultrasound in the detection of inflamed sacroiliac joints. Arthritis Rheum 2005;53:440-4.
37. Klauser AS, De Zordo T, Bellmann-Weiler R, et al. Feasibility of second-generation ultrasound contrast media in the detection of active sacroiliitis. Arthritis Rheum 2009;61:909-16.
38. Mohammadi A, Ghasemi-rad M, Aghdashi M, et al. Evaluation of disease activity in ankylosing spondylitis; diagnostic value of color Doppler ultrasonography. Skeletal Radiol 2013;42:219-24.
39. Aydin SZ, Ash ZR, Tinazzi I, et al. The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development. Ann Rheum Dis 2013;72:992-5.
40. D'Agostino MA, Said-Nahal R, Hacquard-Bouder C, et al. Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional study. Arthritis Rheum 2003;48:523-33.
41. D'Agostino MA, Aegerter P, Bechara K, et al. How to diagnose spondyloarthritis early? Accuracy of peripheral enthesitis detection by power Doppler ultrasonography. Ann Rheum Dis 2011;70:1433-40.
42. de Miguel E, Cobo T, Muñoz-Fernández S, et al. Validity of enthesis ultrasound assessment in spondyloarthropathy. Ann Rheum Dis 2009;68:169-74.
43. de Miguel E, Muñoz-Fernández S, Castillo C, et al. Diagnostic accuracy of enthesis ultrasound in the diagnosis of early spondyloarthritis. Ann Rheum Dis 2011;70:434-9.
44. Feydy A, Lavie-Brion MC, Gossec L, et al. Comparative study of MRI and power Doppler ultrasonography of the heel in patients with spondyloarthritis with and without heel pain and in controls. Ann Rheum Dis 2012;71:498-503.
45. Ibrahim G, Groves C, Chandramohan M, et al. Clinical and ultrasound examination of the leeds enthesitis index in psoriatic arthritis and rheumatoid arthritis. ISRN Rheumatol 2011;2011:731917.
46. Marchesoni A, De Lucia O, Rotunno L, et al. Entheseal power Doppler ultrasonography: a comparison of psoriatic arthritis and fibromyalgia. J Rheumatol 2012;89:29-31.
47. Farouk HM, Mostafa AA, Youssef SS, et al. Value of entheseal ultrasonography and serum cartilage oligomeric matrix protein in the preclinical diagnosis of psoriatic arthritis. Clin Med Insights Arthritis Musculoskelet Disord 2010;3:7-14.
48. Althoff CE, Feist E, Burova E, et al. Magnetic resonance imaging of active sacroiliitis: do we really need gadolinium? Eur J Radiol 2009;71:232-6.
49. Baraliakos X, Hermann KG, Landewé R, et al. Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences. Ann Rheum Dis 2005;64:1141-4.
50. Baraliakos X, Davis J, Tsuji W, et al. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept. Arthritis Rheum 2005;52:1216-23.
51. Blachier M, Coutanceau B, Dougados M, et al. Does the site of magnetic resonance imaging abnormalities match the site of recent-onset inflammatory back pain? The DESIR cohort. Ann Rheum Dis 2013;72:979-85.
52. Bonel HM, Boller C, Saar B, et al. Short-term changes in magnetic resonance imaging and disease activity in response to infliximab. Ann Rheum Dis 2010;69:120-5.
53. Braun J, Baraliakos X, Golder W, et al. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum 2003;48:1126-36.
54. Braun J, Baraliakos X, Hermann KG, et al. Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study. Ann Rheum Dis 2012;71:878-84.
55. Goh L, Suresh P, Gafoor A, et al. Disease activity in longstanding ankylosing spondylitis: a correlation of clinical and magnetic resonance imaging findings. Clin Rheumatol 2008;27:449-55.
56. de Hooge M, van den Berg R, Navarro-Compán V, et al. Magnetic resonance imaging of the sacroiliac joints in the early detection of spondyloarthritis: no added value of gadolinium compared with short tau inversion recovery sequence. Rheumatology (Oxford) 2013;52:1220-4.
57. Hermann KG, Landewé RB, Braun J, et al. Magnetic resonance imaging of inflammatory lesions in the spine in ankylosing spondylitis clinical trials: is paramagnetic contrast medium necessary? J Rheumatol 2005;32:2056-60.
58. Hu Z, Xu M, Li Q, et al. Adalimumab significantly reduces inflammation and serum DKK-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitis. Int J Rheum Dis 2012;15:358-65.
59. Kiltz U, Baraliakos X, Karakostas P, et al. The degree of spinal inflammation is similar in patients with axial spondyloarthritis who report high or low levels of disease activity: a cohort study. Ann Rheum Dis 2012;71:1207-11.
60. Konca S, Keskin D, Ciliz D, et al. Spinal inflammation by magnetic resonance imaging in patients with ankylosing spondylitis: association with disease activity and outcome parameters. Rheumatol Int 2012;32:3765-70.
61. Lambert RG, Salonen D, Rahman P, et al. Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2007;56:4005-14.
62. Lukas C, Braun J, van der Heijde D, et al. Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment. J Rheumatol 2007;34:862-70.
63. Machado P, Landewé R, Braun J, et al. Astratified model for health outcomes in ankylosing spondylitis. Ann Rheum Dis 2011;70:1758-64.
64. Machado P, Landewé RB, Braun J, et al. MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor. Ann Rheum Dis 2012;71:2002-5.
65. Madsen KB, Egund N, Jurik AG. Grading of inflammatory disease activity in the sacroiliac joints with magnetic resonance imaging: comparison between short-tau inversion recovery and gadolinium contrast-enhanced sequences. J Rheumatol 2010;37:393-400.
66. Maksymowych WP, Dhillon SS, Park R, et al. Validation of the spondyloarthritis research consortium of Canada magnetic resonance imaging spinal inflammation index: is it necessary to score the entire spine? Arthritis Rheum 2007;57:501-7.
67. Maksymowych WP, Salonen D, Inman RD, et al. Low-dose infliximab (3 mg/kg) significantly reduces spinal inflammation on magnetic resonance imaging in patients with ankylosing spondylitis: a randomized placebo-controlled study. J Rheumatol 2010;37:1728-34.
68. Marzo-Ortega H, McGonagle D, Jarrett S, et al. Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study. Ann Rheum Dis 2005;64:1568-75.
69. Pedersen SJ, Sørensen IJ, Hermann KG, et al. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors. Ann Rheum Dis 2010;69:1065-71.
70. Puhakka KB, Jurik AG, Schiottz-Christensen B, et al. Magnetic resonance imaging of sacroiliitis in early seronegative spondylarthropathy. Abnormalities correlated to clinical and laboratory findings. Rheumatology (Oxford) 2004;43:234-7.
71. Puhakka KB, Jurik AG, Schiøttz-Christensen B, et al. MRI abnormalities of sacroiliac joints in early spondylarthropathy: a 1-year follow-up study. Scand J Rheumatol 2004;33:332-8.
72. Rudwaleit M, Baraliakos X, Listing J, et al. Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept. Ann Rheum Dis 2005;64:1305-10.
73. Rudwaleit M, Schwarzlose S, Hilgert ES, et al. MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis. Ann Rheum Dis 2008;67:1276-81.
74. Sieper J, Baraliakos X, Listing J, et al. Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab. Rheumatology (Oxford) 2005;44:1525-30.
75. Sieper J, van der Heijde D, Dougados M, et al. Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1). Ann Rheum Dis 2013;72:815-22.
76. Song IH, Hermann K, Haibel H, et al. Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial. Ann Rheum Dis 2011;70:590-6.
77. Visvanathan S, Wagner C, Marini JC, et al. Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab. Ann Rheum Dis 2008;67:511-17.
78. Weber U, Maksymowych WP, Jurik AG. Validation of whole-body against conventional magnetic resonance imaging for scoring acute inflammatory lesions in the sacroiliac joints of patients with spondylarthritis. Arthritis Rheum 2009;61:893-9.
79. Weber U, Lambert RG, Rufibach K, et al. Anterior chest wall inflammation by whole-body magnetic resonance imaging in patients with spondyloarthritis: lack of association between clinical and imaging findings in a cross-sectional study. Arthritis Res Ther 2012;14:R3.
80. Akgul O, Gulkesen A, Akgol G, et al. MR-defined fat infiltration of the lumbar paravertebral muscles differs between non-radiographic axial spondyloarthritis and established ankylosing spondylitis. Mod Rheumatol 2013;23:811-16.
81. Averns HL, Oxtoby J, Taylor HG, et al. Radiological outcome in ankylosing spondylitis: use of the Stoke Ankylosing Spondylitis Spine Score (SASSS). Br J Rheumatol 1996;35:373-6.
82. Baraliakos X, Listing J, Rudwaleit M, et al. Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor alpha antibody infliximab. Ann Rheum Dis 2005;64:1462-6.
83. Baraliakos X, Listing J, Rudwaleit M, et al. Development of a radiographic scoring tool for ankylosing spondylitis only based on bone formation: addition of the thoracic spine improves sensitivity to change. Arthritis Rheum 2009;61:764-71.
84. Braun J, Baraliakos X, Golder W, et al. Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional X rays with magnetic resonance imaging using established and new scoring systems. Ann Rheum Dis 2004;63:1046-55.
85. Creemers MC, Franssen MJ, van't Hof MA, et al. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 2005;64:127-9.
86. Lee JY, Kim JI, Park JY, et al. Cervical spine involvement in longstanding ankylosing spondylitis. Clin Exp Rheumatol 2005;23:331-8.
87. Lubrano E, Marchesoni A, Olivieri I, et al. The radiological assessment of axial involvement in psoriatic arthritis: a validation study of the BASRI total and the modified SASSS scoring methods. Clin Exp Rheumatol 2009;27:977-80.
88. Machado P, Landewe R, Braun J, et al. In ankylosing spondylitis, a decrease in MRI spinal inflammation predicts improvement in spinal mobility independently of patient reported symptomatic improvement. Arthritis Rheum 2012;64(Suppl 10):563.
89. Madsen KB, Jurik AG. Magnetic resonance imaging grading system for active and chronic spondylarthritis changes in the sacroiliac joint. Arthritis Care Res (Hoboken) 2010;62:11-18.
90. Madsen KB, Jurik AG. MRI grading method for active and chronic spinal changes in spondyloarthritis. Clin Radiol 2010;65:6-14.
91. Puhakka KB, Jurik AG, Egund N, et al. Imaging of sacroiliitis in early seronegative spondylarthropathy. Assessment of abnormalities by MR in comparison with radiography and CT. Acta Radiol 2003;44:218-29.
92. Ramiro S, van Tubergen A, Stolwijk C, et al. Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)? Arthritis Res Ther 2013;15:R14.
93. Salaffi F, Carotti M, Garofalo G, et al. Radiological scoring methods for ankylosing spondylitis: a comparison between the Bath Ankylosing Spondylitis Radiology Index and the modified Stoke Ankylosing Spondylitis Spine Score. Clin Exp Rheumatol 2007;25:67-74.
94. Taylor HG, Wardle T, Beswick EJ, et al. The relationship of clinical and laboratory measurements to radiological change in ankylosing spondylitis. Br J Rheumatol 1991;30:330-5.
95. Taylor HG, Gadd R, Beswick EJ, et al. Quantitative radio-isotope scanning in ankylosing spondylitis: a clinical, laboratory and computerised tomographic study. Scand J Rheumatol 1991;20:274-9.
96. Wanders AJ, Landewé RB, Spoorenberg A, et al. What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter. Arthritis Rheum 2004;50:2622-32.
97. Williamson L, Dockerty JL, Dalbeth N, et al. Clinical assessment of sacroiliitis and HLA-B27 are poor predictors of sacroiliitis diagnosed by magnetic resonance imaging in psoriatic arthritis. Rheumatology (Oxford) 2004;43:85-8.
98. Naredo E, Batlle-Gualda E, García-Vivar ML, et al. Power Doppler ultrasonography assessment of entheses in spondyloarthropathies: response to therapy of entheseal abnormalities. J Rheumatol 2010;37:2110-17.
99. Hamdi W, Chelli-Bouaziz M, Ahmed MS, et al. Correlations among clinical, radiographic, and sonographic scores for enthesitis in ankylosing spondylitis. Joint Bone Spine 2011;78:270-4.
100. Aydin SZ, Karadag O, Filippucci E, et al. Monitoring Achilles enthesitis in ankylosing spondylitis during TNF-alpha antagonist therapy: an ultrasound study. Rheumatology (Oxford) 2010;49:578-82.
101. Borman P, Koparal S, Babaoʇlu S, et al. Ultrasound detection of entheseal insertions in the foot of patients with spondyloarthropathy. Clin Rheumatol 2006;25:373-7.
102. Kiris A, Kaya A, Ozgocmen S, et al. Assessment of enthesitis in ankylosing spondylitis by power Doppler ultrasonography. Skeletal Radiol 2006;35:522-8.
103. Balint PV, Kane D, Wilson H, et al. Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis 2002;61:905-10.
104. Milosavljevic J, Lindqvist U, Elvin A. Ultrasound and power Doppler evaluation of the hand and wrist in patients with psoriatic arthritis. Acta Radiol 2005;46:374-85.
105. Spadaro A, Iagnocco A, Perrotta FM, et al. Clinical and ultrasonography assessment of peripheral enthesitis in ankylosing spondylitis. Rheumatology (Oxford) 2011;50:2080-6.
106. McQueen F, Lassere M, Duer-Jensen A, et al. Testing an OMERACT MRI scoring system for peripheral psoriatic arthritis in cross-sectional and longitudinal settings. J Rheumatol 2009;36:1811-15.
107. Mease P, Genovese MC, Gladstein G, et al. Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial. Arthritis Rheum 2011;63:939-48.
108. Poggenborg RP, Boyesen P, Wiell C, et al. Reduction in MRI inflammation during adalimumab therapy in patients with psoriatic arthritis implementation of the OMERACT PsAMRIS scoring method in a follow-up study. Arthritis Rheum 2011;63(Suppl 10):953.
109. Bennett AN, Marzo-Ortega H, Tan AL, et al. Ten-year follow-up of SpA-related oligoarthritis involving the knee: the presence of psoriasis but not HLA-B27 or baseline MRI bone oedema predicts outcome. Rheumatology (Oxford) 2012;51:1099-106.
110. Tan YM, Østergaard M, Doyle A, et al. MRI bone oedema scores are higher in the arthritis mutilans form of psoriatic arthritis and correlate with high radiographic scores for joint damage. Arthritis Res Ther 2009;11:R2.
111. Blackmore MG, Gladman DD, Husted J, et al. Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification. J Rheumatol 1995;22:886-93.
112. Könönen M, Kovero O, Wenneberg B, et al. Radiographic signs in the temporomandibular joint in Reiter's disease. J Orofac Pain 2002;16:143-7.
113. Rahman P, Gladman DD, Cook RJ, et al. Radiological assessment in psoriatic arthritis. Br J Rheumatol 1998;37:760-5.
114. Ravindran J, Cavill C, Balakrishnan C, et al. A modified Sharp score demonstrates disease progression in established psoriatic arthritis. Arthritis Care Res (Hoboken) 2010;62:86-91.
115. Taccari E, Spadaro A, Rinaldi T, et al. Comparison of the Health Assessment Questionnaire and Arthritis Impact Measurement Scale in patients with psoriatic arthritis. Rev Rhum Engl Ed 1998;65:751-8.
116. Baraliakos X, Listing J, Rudwaleit M, et al. Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes. Ann Rheum Dis 2007;66:910-15.
117. Baraliakos X, Listing J, Rudwaleit M, et al. The relationship between inflammation and new bone formation in patients with ankylosing spondylitis. Arthritis Res Ther 2008;10:R104.
118. Baraliakos X, Listing J, von der Recke A, et al. The natural course of radiographic progression in ankylosing spondylitis-evidence for major individual variations in a large proportion of patients. J Rheumatol 2009;36:997-1002.
119. Baraliakos X, Heldmann F, Listing J, et al. The relationship of inflammation, fatty degeneration and the effect of long-term TNF-blocker treatment on the development of new bone formation in patients with ankylosing spondylitis. Arthritis Rheum 2012;64(Suppl 10):780.
120. Chiowchanwisawakit P, Lambert RG, Conner-Spady B, et al. Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis. Arthritis Rheum 2011;63:2215-25.
121. Madsen KB, Schiøttz-Christensen B, Jurik AG. Prognostic significance of magnetic resonance imaging changes of the sacroiliac joints in spondyloarthritis-a followup study. J Rheumatol 2010;37:1718-27.
122. Maksymowych WP, Landewé R, Conner-Spady B, et al. Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. Arthritis Rheum 2007;56:1846-53.
123. Maksymowych WP, Chiowchanwisawakit P, Clare T, et al. Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum 2009;60:93-102.
124. Pedersen SJ, Chiowchanwisawakit P, Lambert RG, et al. Resolution of inflammation following treatment of ankylosing spondylitis is associated with new bone formation. J Rheumatol 2011;38:1349-54.
125. Pedersen SJ, Sørensen IJ, Lambert RG, et al. Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover. Arthritis Rheum 2011;63:3789-800.
126. Poddubnyy D, Haibel H, Listing J, et al. Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum 2012;64:1388-98.
127. Song IH, Hermann KG, Haibel H, et al. Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48. Ann Rheum Dis 2011;70:1257-63.
128. van der Heijde D, Machado P, Braun J, et al. MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis. Ann Rheum Dis 2012;71:369-73.
129. van Tubergen A, Ramiro S, van der Heijde D, et al. Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal study. Ann Rheum Dis 2012;71:518-23.
130. Barkham N, Keen HI, Coates LC, et al. Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum 2009;60:946-54.
131. Nakstad PH, Server A, Josefsen R. Traumatic cervical injuries in ankylosing spondylitis. Acta Radiol 2004;45:222-6.
132. Katzberg RW, Benedetti PF, Drake CM, et al. Acute cervical spine injuries: prospective MR imaging assessment at a level 1 trauma center. Radiology 1999;213:203-12.
133. Jansen TL, Aarts MH, Zanen S, et al. Risk assessment for osteoporosis by quantitative ultrasound of the heel in ankylosing spondylitis. Clin Exp Rheumatol 2003;21:599-604.
134. Frediani B, Allegri A, Falsetti P, et al. Bone mineral density in patients with psoriatic arthritis. J Rheumatol 2001;28:138-43.
135. Speden DJ, Calin AI, Ring FJ, et al. Bone mineral density, calcaneal ultrasound, and bone turnover markers in women with ankylosing spondylitis. J Rheumatol 2002;29:516-21.
136. Toussirot E, Michel F, Wendling D. Bone density, ultrasound measurements and body composition in early ankylosing spondylitis. Rheumatology (Oxford) 2001;40:882-8.
137. Devogelaer JP, Maldague B, Malghem J, et al. Appendicular and vertebral bone mass in ankylosing spondylitis. A comparison of plain radiographs with single- and dual-photon absorptiometry and with quantitative computed tomography. Arthritis Rheum 2002;35:1062-7.
138. Karberg K, Zochling J, Sieper J, et al. Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes. J Rheumatol 2005;32:1290-8.
139. Altindag O, Karakoc M, Soran N, et al. Bone mineral density in patients with ankylosing spondylitis. Romatizma 2008;23:42-5.
140. Jun JB, Joo KB, Her MY, et al. Femoral bone mineral density is associated with vertebral fractures in patients with ankylosing spondylitis: a cross-sectional study. J Rheumatol 2006;33:1637-41.
141. Meirelles ES, Borelli A, Camargo OP. Influence of disease activity and chronicity on ankylosing spondylitis bone mass loss. Clin Rheumatol 1999;18:364-8.
142. Mullaji AB, Upadhyay SS, Ho EK. Bone mineral density in ankylosing spondylitis. DEXA comparison of control subjects with mild and advanced cases. J Bone Joint Surg Br 1994;76:660-5.
143. Will R, Palmer R, Bhalla AK, et al. Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet 1989;2:1483-5.
144. Franck H, Meurer T, Hofbauer LC. Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis. J Rheumatol 2004;31:2236-41.
145. Gilgil E, Kaçar C, Tuncer T, et al. The association of syndesmophytes with vertebral bone mineral density in patients with ankylosing spondylitis. J Rheumatol 2005;32:292-4.
146. Mermerci Ba¸kan B, Pekin Doʇan Y, Sivas F, et al. The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis. Rheumatol Int 2010;30:375-81.
147. Muntean L, Rojas-Vargas M, Font P, et al. Relative value of the lumbar spine and hip bone mineral density and bone turnover markers in men with ankylosing spondylitis. Clin Rheumatol 2011;30:691-5.
148. Taylan A, Sari I, Akinci B, et al. Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis. BMC Musculoskelet Disord 2012;13:191.
149. Ulu MA, Çevik R, Dilek B. Comparison of PA spine, lateral spine, and femoral BMD measurements to determine bone loss in ankylosing spondylitis. Rheumatol Int 2012;29:29.
150. Will R, Palmer R, Bhalla AK, et al. Bone loss as well as bone formation is a feature of progressive ankylosing spondylitis. Br J Rheumatol 1990;29:498-9.
151. Vasdev V, Bhakuni D, Garg MK, et al. Bone mineral density in young males with ankylosing spondylitis. Int J Rheum Dis 2011;14:68-73.
152. Korczowska I, Przepiera-Bedzak H, Brzosko M, et al. Bone tissue metabolism in men with ankylosing spondylitis. Adv Med Sci 2011;56:264-9.
153. Sarikaya S, Basaran A, Tekin Y, et al. Is osteoporosis generalized or localized to central skeleton in ankylosing spondylitis? J Clin Rheumatol 2007;13:20-4.
154. Baek HJ, Kang SW, Lee YJ, et al. Osteopenia in men with mild and severe ankylosing spondylitis. Rheumatol Int 2005;26:30-4.
155. Capaci K, Hepguler S, Argin M, et al. Bone mineral density in mild and advanced ankylosing spondylitis. Yonsei Med J 2003;44:379-84.
156. Donnelly S, Doyle DV, Denton A, et al. Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 1994;53:117-21.
157. Klingberg E, Lorentzon M, Mellström D, et al. Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment. Arthritis Res Ther 2012;14:R108.
158. Grazio S, Kusić Z, Cvijetić S, et al. Relationship of bone mineral density with disease activity and functional ability in patients with ankylosing spondylitis: a cross-sectional study. Rheumatol Int 2012;32:2801-8.
159. Park MC, Chung SJ, Park YB, et al. Bone and cartilage turnover markers, bone mineral density, and radiographic damage in men with ankylosing spondylitis. Yonsei Med J 2008;49:288-94.
160. van der Weijden MA, van Denderen JC, Lems WF, et al. Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies. Clin Rheumatol 2011;30:497-503.
161. Grisar J, Bernecker PM, Aringer M, et al. Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation. J Rheumatol 2002;29:1430-6.
162. Pedreira PG, Pinheiro MM, Szejnfeld VL. Bone mineral density and body composition in postmenopausal women with psoriasis and psoriatic arthritis. Arthritis Res Ther 2011;13:R16.
163. Dheda K, Cassim B, Patel N, et al. A comparison of bone mineral density in Indians with psoriatic polyarthritis and healthy Indian volunteers. Clin Rheumatol 2004;23:89.
164. Grazio S, Cvijetić S, Vlak T, et al. Osteoporosis in psoriatic arthritis: is there any? Wien Klin Wochenschr 2011;123:743-50.
165. Gratacós J, Collado A, Pons F, et al. Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study. Arthritis Rheum 1999;42:2319-24.
166. Haugeberg G, Bennett AN, McGonagle D, et al. Bone loss in very early inflammatory back pain in undifferentiated spondyloarthropathy: a 1-year observational study. Ann Rheum Dis 2010;69:1364-6.
167. Kaya A, Ozgocmen S, Kamanli A, et al. Bone loss in ankylosing spondylitis: does syndesmophyte formation have an influence on bone density changes? Med Princ Pract 2009;18:470-6.
168. Maillefert JF, Aho LS, El Maghraoui A, et al. Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study. Osteoporos Int 2001;12:605-9.
169. Anandarajah AP, El-Taha M, Peng C, et al. Association between focal erosions and generalised bone loss in psoriatic arthritis. Ann Rheum Dis 2011;70:1345-7.
170. Arends S, Spoorenberg A, Bruyn GA, et al. The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis. Osteoporos Int 2011;22:1431-9.
171. Briot K, Durnez A, Paternotte S, et al. Bone oedema on MRI is highly associated with low bone mineral density in patients with early inflammatory back pain: results from the DESIR cohort. Ann Rheum Dis 2013;72:1914-19.
172. Dos Santos FP, Constantin A, Laroche M, et al. Whole body and regional bone mineral density in ankylosing spondylitis. J Rheumatol 2001;28:547-9.
173. El Maghraoui A, Borderie D, Cherruau B, et al. Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol 1999;26:2205-9.
174. Mitra D, Elvins DM, Collins AJ. Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures. J Rheumatol 1999;26:2201-4.
175. Lange U, Kluge A, Strunk J, et al. Ankylosing spondylitis and bone mineral density-what is the ideal tool for measurement? Rheumatol Int 2005;26:115-20.
176. Schueller-Weidekamm C, Mascarenhas VV, Sudol-Szopinska I, et al. Imaging and interpretation of axial spondylarthritis: the radiologist's perspective - consensus of the Arthritis Subcommittee of the ESSR. Semin Musculoskelet Radiol 2014;18:265-79.